Google's parent company Alphabet and British pharmaceutical company GlaxoSmithKline (GSK) on Monday announced an alliance to form a $715 million bioelectronics company, Galvani Bioelectronics. It will create tiny implantable devices that will modify electrical nerve signals to modulate irregular impulses during illnesses. Alphabet's Verily Life Sciences will hold 45% stake while GSK will hold 55%.